GB9308652D0 - Anti-inflammatory compounds - Google Patents

Anti-inflammatory compounds

Info

Publication number
GB9308652D0
GB9308652D0 GB939308652A GB9308652A GB9308652D0 GB 9308652 D0 GB9308652 D0 GB 9308652D0 GB 939308652 A GB939308652 A GB 939308652A GB 9308652 A GB9308652 A GB 9308652A GB 9308652 D0 GB9308652 D0 GB 9308652D0
Authority
GB
United Kingdom
Prior art keywords
inflammatory compounds
inflammatory
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939308652A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB939308652A priority Critical patent/GB9308652D0/en
Publication of GB9308652D0 publication Critical patent/GB9308652D0/en
Priority to JP6524018A priority patent/JPH08509487A/ja
Priority to APAP/P/1994/000637A priority patent/AP454A/en
Priority to ZA942911A priority patent/ZA942911B/xx
Priority to PCT/GB1994/000886 priority patent/WO1994025431A1/fr
Priority to HU9501810A priority patent/HUT71556A/hu
Priority to JP6524019A priority patent/JPH08509718A/ja
Priority to EP94913700A priority patent/EP0696272A1/fr
Priority to TW083103703A priority patent/TW269679B/zh
Priority to AU65749/94A priority patent/AU6574994A/en
Priority to AU65750/94A priority patent/AU6575094A/en
Priority to PCT/GB1994/000885 priority patent/WO1994025430A1/fr
Priority to CA002161544A priority patent/CA2161544A1/fr
Priority to IL10943094A priority patent/IL109430A0/xx
Priority to EP94913699A priority patent/EP0696271A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB939308652A 1993-04-27 1993-04-27 Anti-inflammatory compounds Pending GB9308652D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB939308652A GB9308652D0 (en) 1993-04-27 1993-04-27 Anti-inflammatory compounds
EP94913699A EP0696271A1 (fr) 1993-04-27 1994-04-26 Derives de l'acide hydroxamique inhibiteurs de la cyclooxygenase et de la 5-lipoxygenase
JP6524019A JPH08509718A (ja) 1993-04-27 1994-04-26 シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するＮ（３−ビフェニリル−１（ｓ）−メチル−２−プロペニル）アセトヒドロキサム酸誘導体
TW083103703A TW269679B (fr) 1993-04-27 1994-04-26
ZA942911A ZA942911B (en) 1993-04-27 1994-04-26 Therapeutic compounds
PCT/GB1994/000886 WO1994025431A1 (fr) 1993-04-27 1994-04-26 Derives de l'acide acetohydroxamique n (3-biphenylyl-1(s)-methyl-2-propenyl) inhibiteurs de la cyclooxygenase et de la 5-lipoxygenase
HU9501810A HUT71556A (en) 1993-04-27 1994-04-26 Cyclooxygenase and 5-lipoxygenase inhibiting n(3-biphenylyl-1(s)-methyl-2-propenyl) acetohydroxamic acid derivatives, pharmaceutical compns. contg. them and process to prepare the said compds.
JP6524018A JPH08509487A (ja) 1993-04-27 1994-04-26 シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するヒドロキサム酸誘導体
EP94913700A EP0696272A1 (fr) 1993-04-27 1994-04-26 Derives de l'acide acetohydroxamique n (3-biphenylyl-1(s)-methyl-2-propenyl) inhibiteurs de la cyclooxygenase et de la 5-lipoxygenase
APAP/P/1994/000637A AP454A (en) 1993-04-27 1994-04-26 Therapeutic compounds with hydroxamic acid derivatives.
AU65749/94A AU6574994A (en) 1993-04-27 1994-04-26 Cyclooxygenase and 5-lipoxygenase inhibiting hydroxamic acid derivatives
AU65750/94A AU6575094A (en) 1993-04-27 1994-04-26 Cyclooxygenase and 5-lipoxygenase inhibiting n(3-biphenylyl-1(s)-methyl-2-propenyl) acetohydroxamic acid derivatives
PCT/GB1994/000885 WO1994025430A1 (fr) 1993-04-27 1994-04-26 Derives de l'acide hydroxamique inhibiteurs de la cyclooxygenase et de la 5-lipoxygenase
CA002161544A CA2161544A1 (fr) 1993-04-27 1994-04-26 Derives de l'acide n-(3-biphenylyl-1(s)-methyl-2-propenyl)acetohydroxamique, inhibiteurs de la cyclooxygenase et de la 5-lipoxygenase
IL10943094A IL109430A0 (en) 1993-04-27 1994-04-26 Hydroxamic acid derivatives, their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939308652A GB9308652D0 (en) 1993-04-27 1993-04-27 Anti-inflammatory compounds

Publications (1)

Publication Number Publication Date
GB9308652D0 true GB9308652D0 (en) 1993-06-09

Family

ID=10734525

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939308652A Pending GB9308652D0 (en) 1993-04-27 1993-04-27 Anti-inflammatory compounds

Country Status (6)

Country Link
EP (1) EP0696271A1 (fr)
JP (1) JPH08509487A (fr)
AU (1) AU6574994A (fr)
GB (1) GB9308652D0 (fr)
WO (1) WO1994025430A1 (fr)
ZA (1) ZA942911B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0807626A4 (fr) * 1995-02-02 1998-05-06 Nikken Chemicals Co Ltd Derives de n-hydroxyuree
JPH11507670A (ja) * 1995-06-12 1999-07-06 ジー．ディー．サール アンド カンパニー シクロオキシゲナーゼ−２インヒビターと５−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療
WO2005061448A1 (fr) * 2003-12-24 2005-07-07 Monash University Compositions et methodes de traitement d'affections vasculaires
CN103450077B (zh) 2007-06-08 2016-07-06 满康德股份有限公司 IRE-1α抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK117986A (da) * 1985-03-16 1986-09-17 Wellcome Found Arylderivater, fremgangsmaader til deres fremstilling og deres anvendelse
PL154186B1 (en) * 1987-07-15 1991-07-31 Wellcome Found Method for manufacturing arylic derivatives of the hydroxamic acid
FI900536A0 (fi) * 1989-02-03 1990-02-02 Wellcome Found Anti-inflammatoriska arylkompositioner.
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途
US5169854A (en) * 1992-02-26 1992-12-08 Abbott Laboratories N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity

Also Published As

Publication number Publication date
ZA942911B (en) 1995-10-26
EP0696271A1 (fr) 1996-02-14
JPH08509487A (ja) 1996-10-08
AU6574994A (en) 1994-11-21
WO1994025430A1 (fr) 1994-11-10

Similar Documents

Publication Publication Date Title
GB9304620D0 (en) Compounds
GB9310978D0 (en) Compounds
EP0765305A4 (fr) Composes anti-inflammatoires
GB9302016D0 (en) Compounds
GB9215921D0 (en) Anti-inflammatory compounds
GB9308652D0 (en) Anti-inflammatory compounds
GB9315801D0 (en) Compounds
GB9313144D0 (en) Compounds
GB9307400D0 (en) Compounds
GB9315800D0 (en) Compounds
GB9318432D0 (en) Anti-inflammatory compounds
EP0733044A4 (fr) Composes
GB9223161D0 (en) Anti-inflammatory compounds
GB9216682D0 (en) Anti-inflammatory compounds
GB9203512D0 (en) Anti-inflammatory compounds
PL315061A1 (en) Di-ter-butylophenolic compounds suitable as anti-inflammatory agents
GB9119554D0 (en) Anti-inflammatory compounds
GB9514718D0 (en) Anti-inflammatory Compounds
GB9312688D0 (en) Compounds
GB9303808D0 (en) Compounds
GB9300090D0 (en) Compounds
GB9300088D0 (en) Compounds
GB9302619D0 (en) Organiz compounds
GB9313185D0 (en) Compounds
GB9302621D0 (en) Organiz compounds